STEM News Today
SEE OTHER BRANDS

Global take on science and technology news

STEM News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.

Press releases published on June 25, 2025

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions

RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced results …

Latin Metals Amends Agreement for 100% Ownership of Drill-Ready Cerro Bayo Silver-Gold Project, Santa Cruz Province, Argentina

Latin Metals Amends Agreement for 100% Ownership of Drill-Ready Cerro Bayo Silver-Gold Project, Santa Cruz Province, Argentina

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") - (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce that it has entered into an amending agreement (the "Amended Agreement") to complete …

ALPHAMIN ANNOUNCES APPOINTMENT OF DIRECTOR

ALPHAMIN ANNOUNCES APPOINTMENT OF DIRECTOR

GRAND BAIE, MAURITIUS, June 25, 2025 (GLOBE NEWSWIRE) -- Alphamin Resources Corp. (AFM:TSXV, APH:JSE AltX) (the “Company” or “Alphamin”) announced today that, subject to regulatory approval, Mr. John Robertson, a Mauritian resident, has been appointed as a …

Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech

Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech

Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …

AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand

AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand

New eBee X units enhance capabilities across agriculture, urban planning, and strategic applications WICHITA, Kan., June 25, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging …

BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort

BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort

London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- As Bitcoin holds steady above $105,000 and Ethereum remains strong beyond $2,500, global investors are increasingly turning to passive income solutions in the crypto sector. Riding this wave is BTC Miner, a …

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

BERKELEY, Calif. and MAINZ, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its …

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s pipeline under the name EVX-B4 Urgent need for preventive …

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of …

EnCorps Invites STEM Professionals to Attend Inaugural Learning Summit at Columbia Memorial Space Center

EnCorps Invites STEM Professionals to Attend Inaugural Learning Summit at Columbia Memorial Space Center

The non-profit organization kicks off the new school year fostering connection and empowerment to motivate students LOS ANGELES, CA, UNITED STATES, June 24, 2025 /⁨EINPresswire.com⁩/ -- EnCorps, a leading non-profit dedicated to addressing educational …

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

– Favorable safety and tolerability profile, as well as pharmacokinetics supporting once-daily oral dosing, continued to be observed in final 400 mg cohort – – Mean plasma HBV DNA reductions of 3.2 logs IU/mL over 28 days of treatment for 400 mg cohort …

Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation

Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation

BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading product experience management (PXM) platform that empowers brands, retailers, and distributors to win on the digital shelf, is thrilled to announce the appointment of Cory McIntyre as Vice …

Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII

Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII

SEATTLE, June 25, 2025 (GLOBE NEWSWIRE) -- Nametag, the leader in workforce identity verification, today announced the general availability of Enterprise Data Custody. Enterprise Data Custody allows organizations to store all personally identifiable …

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

Combination cohort initiated following successful review of monotherapy cohort Over 100 participants dosed to-date in monotherapy cohort Priority are Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer Data update on schedule for later this …

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that three …

Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile

Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile

New clinical trial data with Bryn Pharma’s second-generation epinephrine nasal spray expected in Q3 2025 The trial employs an upgraded two-spray nasal spray device providing additional reliability and user experience enhancements Trial includes evaluation …

Media Advisory - Energy Sector Gains New Edge in Vegetation and Methane Emissions Monitoring with Maxar and Satelytics Partnership

Media Advisory - Energy Sector Gains New Edge in Vegetation and Methane Emissions Monitoring with Maxar and Satelytics Partnership

PERRYSBURG, Ohio, June 25, 2025 (GLOBE NEWSWIRE) -- Maxar and its partner Satelytics are announcing today an expansion of their offerings to the energy industry. In addition to the methane monitoring solution that has been on the market for several years, …

ORYZON to Host Virtual KOL Event on July 9, 2025

ORYZON to Host Virtual KOL Event on July 9, 2025

MADRID and CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that it will host a virtual KOL event on …

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package Includes Positive Results from Phase 3 STRIVE-ON Safety Trial of GTx-104 Submission Has the Potential to Trigger …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service